Carotenoids in the Skin and Immune Aging
1 other identifier
observational
40
1 country
1
Brief Summary
This study aims to examine the connection between the level of carotenoids in the skin and a number of immune related health parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2025
CompletedStudy Start
First participant enrolled
October 9, 2025
CompletedFirst Posted
Study publicly available on registry
October 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedDecember 15, 2025
October 1, 2025
5 months
September 30, 2025
December 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Skin carotenoid levels and skin aging features
We will assess the skin carotenoid levels' correlation with skin aging features, such as wrinkles, fine lines, and age spots.
one day
Secondary Outcomes (2)
Skin carotenoid levels and biomarkers of aging
one day
Skin carotenoid levels and self-reported perception of health
2 weeks
Study Arms (2)
Young adult
Participants are 18 to 30 years old.
Older adult
Participants are over 65 years old.
Eligibility Criteria
Healthy individuals who are either between 18 to 30 years old or over 65 years old.
You may qualify if:
- Willing and able to provide written informed consent
- Age 18-30 years OR 65 years and older
- Healthy individuals without uncontrolled medical conditions (over the counter inhaled and topical steroids allowed)
- Fiitzpatrick I-VI (all skin types)
You may not qualify if:
- Pregnant or breastfeeding
- uncontrolled medical conditions
- Skin conditions on the upper extremity that would interfere with skin measurements of carotenoid levels such as active atopic dermatitis or psoriasis
- Concurrent use of medications that affect the immune system, within 4 weeks of enrollment (eg. prednisone, biologics, methotrexate, rapamycin, prescription topical steroids, prescription inhaled steroids, others)
- Unable to follow study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Health - General Dermatology Clinic
Redwood City, California, 94063, United States
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Dermatology
Study Record Dates
First Submitted
September 30, 2025
First Posted
October 28, 2025
Study Start
October 9, 2025
Primary Completion
March 1, 2026
Study Completion
April 1, 2026
Last Updated
December 15, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share